Speaker illustration

Doctor Niccolo' Maurizi

University of Florence, Florence (Italy)

Member of:

European Society of Cardiology

Prevalence and clinical correlates of clinical red flags for rare diseases in consecutive patients presenting with HCM phenotype

Event: ESC Congress 2022

Topic: Hypertrophic Cardiomyopathy

Session: Hypertrophic cardiomyopathy: not so rare, but not so easy

Thumbnail

Unusual case of Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy.

Event: ESC Congress 2022

Topic: Clinical

Session: MINOCA in clinical practice

Thumbnail

Development and validation of a smartphone based app to support the differential diagnosis in patients with primary left ventricular hypertrophy

Event: ESC Congress 2022

Topic: Mobile Apps

Session: e-Cardiology/Digital health 1

Thumbnail

External validation study of the 2014 European Society of Cardiology Guidelines in relation to 2020 ACC/AHA guidelines on sudden cardiac death prevention in hypertrophic cardiomyopathy

Event: EHRA 2022

Topic: Congenital Heart Disease and Paediatric Cardiology, Other

Session: ePosters Day 1

Thumbnail

Lifetime mortality associated with hypertrophic cardiomyopathy: 28-year outcome of an historical cohort

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Advances in Pathophysiology and Treatment of Hypertrophic Cardiomyopathy

Thumbnail

Feasibility of a combined mobile-health electrocardiographic and rapid diagnostic test screening for Chagas-related cardiac alterations

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Remote Patient Monitoring and Telehealth, Other

Session: e-Cardiology / Digital Health ePosters

Thumbnail

Telemedicine cardiovascular screening program in low-income settings by smartphone based technology

Event: ESC Congress 2018

Topic: Remote Patient Monitoring and Telehealth, Other

Session: Remote patient monitoring and telemedecine

Thumbnail

Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Cardiomyopathies: diagnosis and outcome

Thumbnail

Age-specific prevalence of cardiac structural alterations in a large consecutive cohort of athletes by pre-participation screening

Event: ESC Congress 2018

Topic: Pre-Competition Screening and Sports Eligibility

Session: Cardiovascular risk in athletes

Thumbnail

Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Cardiac phenotyping and outcome implications

Thumbnail

ESC 365 is supported by

logo Novo Nordisk